Zealand Pharma A/S
PHARMACEUTICAL PARENTERAL COMPOSITION OF DUAL GLP1/2 AGONIST
Last updated:
Abstract:
The present invention relates to pharmaceutical compositions suitable for parenteral administration in human subjects. In particular, the present invention relates to isotonic pharmaceutical compositions for parenteral administration.
Status:
Application
Type:
Utility
Filling date:
12 Jun 2020
Issue date:
30 Jun 2022